|
27 |
[2019.04.16] CUBEBIO signs a contract with Samsung Securities Co., Ltd as a lead underwriter for KOSDAQ listings
|
2019-07-23 |
17,051 |
|
26 |
[2019.02.18] CUBEBIO obtains permission for sales of in vitro diagnostics in China
|
2019-07-23 |
13,100 |
|
25 |
[2019.01.29] CUBEBIO signs a contract with a China-based large asset management company with regards to NASDAQ listings
|
2019-07-23 |
14,551 |
|
24 |
[2019.01.15] CUBEBIO gains permission for cancer diagnostic devices from the FDA of the Philippines
|
2019-07-23 |
12,742 |
|
23 |
[2019.01.08] CUBEBIO is awarded the Korean Patent Grand Prize
|
2019-07-23 |
13,837 |
|
22 |
[2019.01.03] Identifying existence of tumor cells at an early stage through the analysis of urine
|
2019-07-23 |
12,989 |
|
21 |
[2018.12.27] CUBEBIO signs a strategic cooperation agreement for IPO in Hong Kong
|
2019-07-23 |
13,971 |
|
20 |
[2018.12.20] CUBEBIO attracts an investment worth KRW 30 billion from Cybernaut, a Chiense
|
2019-07-23 |
13,915 |
|
19 |
[2018.12.24] CUBEBIO signs a contract with a law firm, JIPYONG, and others for consultation about Asian market entry and listing
|
2019-07-23 |
13,099 |
|
18 |
[2018.10.10] CUBEBIO advances into the global market through overseas Chinese networks.
|
2019-07-23 |
15,310 |
